Sentiment Analysis of the earnings transcript to help figure out if there are any bullish or bearish sentiments that could be gathered from it. We're doing ML and AI based analysis on the earnings call to get some more insights.
Please consider a small donation if you think this website provides you with relevant information
| Statement |
|---|
| So we feel pretty good about where things are |
| That company has exhibited 12 consecutive quarters of EBITDA growth, steady performance, continued upward trend, modest increases every quarter, but 12 quarters in a row coming out of the pandemic of EBITDA increases |
| With attractive new originations, a stable portfolio and reduced non-accruals, we benefited from continued execution of our strategy in 2023 and remain committed to delivering a non-volatile cash flow stream to our investors through consistent income and solid credit performance |
| And we continue to focus on sourcing transactions with significant equity cushions, attractive leverage levels, strong documentation and attractive spreads relative to not only the current market but also historical originations through our disciplined underwriting, prudent portfolio construction and conservative approach to risk management |
| As Aren previewed, we had another strong quarter on the earnings front |
| We continue to be well positioned on the right side of our balance sheet |
| Total non-accruals were effectively flat quarter-over-quarter, and we're very pleased to report that Dermatology Associates was successfully recapitalized in early February with the lenders taking equity control |
| At the same time, the total dividend level also represents an attractive yield of over 12% based on the recent share price |
| This total dividend level reflects an increase of 9% over the previous $0.44 per share and reflects the earnings power and stability of our portfolio despite a complex macroeconomic environment |
| We continue to see our financial performance benefit from the higher base rate environment |
| Tactical origination activity, strong credit fundamentals and the current rate environment drove record income for CGBD |
| We continue to be pleased with the overall credit performance of our existing portfolio, with revenue and EBITDA up quarter-over-quarter and since inception |
| So we remain highly confident in our ability to comfortably meet and exceed our new $0.40 base dividend and continue paying out supplemental dividends each quarter |
| And as Tom will discuss in detail later, we expect these levels to improve in the coming quarter |
| The result was net investment income for the fourth quarter of $28 million or $0.56 per share, up nearly 8% from the prior quarter |
| As a result of our continued execution of our strategy, the quality of our portfolio and our confidence in the future, beginning this quarter, we are increasing the base dividend by $0.03 from $0.37 to $0.40 per share |
| This increase will be driven by the continued positive impact of base rates and an increase in both other income and OID acceleration, which were aided by prepayment activity |
| This increase in valuations combined with Q4 earnings exceeding the dividend resulted in our NAV increasing from $16.86 to $16.99 per share |
| We continue to see overall stability in credit quality across the book |
| That's a positive |
| Our flexible origination capabilities enabled us to source transactions from the lower end of the middle market at $25 million of EBITDA and opportunistically all the way up to $450 million of EBITDA in the last year |
| In our view, our new dividend policy, which Tom will expand upon later, provides a sustainable base dividend along with a transparent framework for supplemental dividends that will enable investors to better anchor their expectations |
| With this backdrop throughout the year, our investment team leveraged the breadth and depth of the One Carlyle platform to drive value in the evolving market environment by generating significant volume across our existing portfolio of borrowers and Carlyle's broad sourcing network |
| The company's performance, it's stable and improving, and we'll look at the right time to exit the investment |
| And we've grown the base dividend by 25% since 2022 |
| The first question isn't, oh, how many more deals can we do? The first question is, how do we actually create the cleanest, most non-volatile cash flow streams that we can? So that can -- is leverage going to stay down at one turn forever? No, we don't mean it to, but in this market based on our current base returns, we actually have the benefit of being able to do that |
| Compared to the prior year, portfolio company revenue and EBITDA both expanded by an average of approximately 13% and compared to the prior quarter, 1% and 3%, respectively |
| That's the other deal that's on non-accrual with value that again improved |
| This positioning allows us to remain opportunistic as the macroeconomic environment evolves and deal activity looks to pick up in 2024 |
| In terms of the future, it's stable growth |
| Statement |
|---|
| 2023 was defined by market volatility, slow private equity capital formation and muted M&A activity for most of the year |
| We don't have very much in the portfolio, but we've seen lower demand in consumer-driven businesses and then across our industrial book, just destocking, and one of the credits just had -- we've had a couple of credits in the book, and that was one of the downgrade just the general destocking in the current environment |
| For context, private equity deal activity and M&A activity were down significantly in '23 compared to '22 and '21, though there was a pickup in M&A activity in the fourth quarter |
| The overarching theme I'd give you, though, is sometimes when we're moving things from 2 to 3, 3 to 4, it is less a function -- certainly if it's a 5, there's a function of there are serious issues |
| By the second half of the year, and you and I have talked about this behind closed doors as well as the upper part of the market got a little bit more crowded, CLO bid came back, significant retail flows went into other direct lending strategies and some of our peers, we skewed back down to the core mid-market |
| Risk has increased probably for those particular credits |
| And we at times avoid those so that we can actually get overpaid in other parts of the market |
| Earlier in '23 based on lower prepayment activity, it was lower in a couple of quarters |
| But importantly, we're not worried about losing money |
| I mean you've noted that you're at one of the lowest leverage points in quite a while |
| And I'd say for all of the market, not just the mid-market, I'd say the leverage levels are continuing to be lower than historical leverage levels |
| I guess the question is, to the extent that you are seeing portfolio companies with any particular challenges, where is that coming from? Is it still inflationary pressures? Is it labor cost? Curious what you're seeing |
| It was a pop versus the rest of 2023, which was abnormally low |
| These risks and uncertainties could cause actual results to differ materially from those indicated |
| Statutory leverage was about 1.2x, and net financial leverage ended the quarter modestly lower, right about one turn, the lowest level since early 2022 |
| But this, of course, had been a long challenged credit, where you had restructured the debt somewhat previously |
| Leverage is up, EBITDA is likely down from when we closed |
Please consider a small donation if you think this website provides you with relevant information